J2779 Injection, susvimo 0.1 milligrams
Also known as: susvimo, ranibizumab sustained-release
Injection of ranibizumab (Susvimo sustained-release implant formulation), 0.1 milligrams, for extended intravitreal delivery to retinal tissues.
In Plain Language
long-lasting eye injection
Clinical Context
Used as a sustained-release intravitreal implant for age-related macular degeneration (AMD) requiring long-term anti-VEGF therapy.
RVU Information
CPT J2779 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2779?
CPT J2779 (Injection, susvimo 0.1 milligrams) is a J Codes (Drugs) code. Injection of ranibizumab (Susvimo sustained-release implant formulation), 0.1 milligrams, for extended intravitreal delivery to retinal tissues.
How is J2779 administered?
CPT J2779 is administered by a healthcare provider, typically via injection or infusion. Used as a sustained-release intravitreal implant for age-related macular degeneration (AMD) requiring long-term anti-VEGF therapy. It is used by Ophthalmology, Retina.
When is CPT J2779 used?
Used as a sustained-release intravitreal implant for age-related macular degeneration (AMD) requiring long-term anti-VEGF therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.